Abbott Laboratories ABT
US equityMarket cap rank #93Medical DevicesBrain-Computer InterfaceInfectious DiseaseMpox (monkeypox)
$109.93 −$3.67 (-3.23%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $109.93 0.00%
Open$111.08
Prev close$113.60
Day range$109.81 – $111.81
Volume8.35M
Market cap$190.39B
P/E (TTM)40.9
Dividend yield2.26%
ABT Stock News
Headlines matching Abbott Laboratories or the ABT ticker, most recent first.
- Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $112
- TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
- Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $112
- TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
- Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $125
- J.P. Morgan Maintains Abbott Laboratories(ABT.US) With Buy Rating
- Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating
- Abbott Laboratories(ABT.US) Officer Sells US$46.2 Million in Common Stock
- Piper Sandler Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $118
- Jefferies Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
- BTIG Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $134
- TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $135 Positive
- BofA Securities Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $115
- William Blair Maintains Abbott Laboratories(ABT.US) With Buy Rating
- Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Announces Target Price $125
No comments yet — be the first to weigh in on ABT.
Sign in to join the discussion.